30

ChemPartner PharmaTech Co LtdSHE 300149 Stock Report

Last reporting period 30 Sep, 2023

Updated 19 Sep, 2024

Last price

Market cap $B

0.18

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300149.SZ Stock Analysis

30

Uncovered

ChemPartner PharmaTech Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-28/100

Low score

Market cap $B

0.18

Dividend yield

0.38 %

Shares outstanding

450.56 B

ChemPartner PharmaTech Co., Ltd. engages in the research and development, production, and sale of prebiotic products. The company is headquartered in Guangzhou, Guangdong and currently employs 2,636 full-time employees. The company went IPO on 2010-12-22. The firm's main products include fructooligosaccharides and galactooligosaccharides. The firm owns brands names of FOS and GOS. The firm's products are mainly used in nutrition and health products, dairy products, beverages, baked goods, functional candy and snack foods. The firm distributes its products mainly in domestic market, with South China as its main market.

View Section: Eyestock Rating